Ranchi sadar hosp to start CT scan services this week
1
2
Ranchi: The Ranchi sadar hospital will roll out CT scan services later this week for its patients, its management said on Monday.
A three-day trial run of the machine, which will be operated under public-private partnership (PPP) mode, began on Sunday.
"The facility will be fully functional and open to patients after the trial. An MRI machine will also be installed in 15 days," civil surgeon Dr Prabhat Kumar said.
The hospital's MoU with Krishna Diagnostics mandate that all patients admitted under the Ayushman Bharat health scheme will be provided with free CT scan services. For others, tests will be conducted based on the Central Govt Health Scheme (CGHS) rates, beginning from Rs 1,050.
Dr Kumar said, "An added benefit of the partnership is the revenue-sharing clause outlined in the MoU. Krishna Diagnostics will share 15% of its profits with the Sadar Hospital. These funds would contribute to the development of hospital infrastructure and services, benefiting patients."
The hospital would also set up a Cath Lab for cardiac care. This facility, being constructed at a cost of around Rs 8 crore, will provide advanced treatment options for heart patients, reducing the need for referrals to private hospitals.
Lauding the move, Rekha Devi of Kanke said, "I was delaying a test as the price of CT scans in private centres was beyond my reach. Undergoing the test at the sadar hospital will save both money and time."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
ICICI Securities maintains Add on Apollo Hospitals, raises target price to Rs 7,500
Apollo Hospitals Enterprise key products/revenue segments include HealthCare Services and Other Operating Revenue for the year ending 31-Mar-2024. Financials For the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 5653.30 crore, up 1.12% from last quarter Total Income of Rs 5590.70 crore and up 13.70% from last year same quarter Total Income of Rs 4972.00 crore. The company has reported net profit after tax of Rs 404.00 crore in the latest quarter. The company's top management includes C Reddy, Chatterjee, Bijapurkar, Doraiswamy, Mrs.V Kavitha Dutt, Mittal, Reddy, Reddy, Reddy, Mr.M B N Rao. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 crore shares outstanding. Live Events Investment Rationale ICICI Securities has increased the revenue/EBITDA/PAT estimates of Apollo Hospitals Enterprise by ~1%/6%/7% for FY26 and 6%/13%/15% for FY27, factoring in faster growth and better margins in pharmacy business. The stock currently trades at EV/EBITDA of 27.4x FY26E and 22.3x FY27E. The brokerage maintains its ADD rating with a higher target price of Rs 7,500 (earlier Rs 6,700). ICICI Securities values the hospital business at 25x FY27E EV/EBITDA, HealthCo at 2.5x FY27E EV/sales and AHLL at 18x FY27E EV/EBITDA. Downside risks include higher competition in pharmacy business; and slower occupancy ramp up at new hospitals. Promoter/FII Holdings Promoters held 29.34 per cent stake in the company as of 31-Mar-2025, while FIIs owned 42.74 per cent, DIIs 22.1 per cent. (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel ICICI Securities has maintained an Add call on Apollo Hospitals Enterprise with a revised target price of Rs 7,500 (earlier Rs 6,700). The current market price of Apollo Hospitals Enterprise is Rs 6798. Apollo Hospitals Enterprise, incorporated in 1979, is a Large Cap company with a market cap of Rs 97953.30 crore, operating in the Hospitals & Allied Services Hospitals Enterprise key products/revenue segments include HealthCare Services and Other Operating Revenue for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 5653.30 crore, up 1.12% from last quarter Total Income of Rs 5590.70 crore and up 13.70% from last year same quarter Total Income of Rs 4972.00 crore. The company has reported net profit after tax of Rs 404.00 crore in the latest company's top management includes C Reddy, Chatterjee, Bijapurkar, Doraiswamy, Mrs.V Kavitha Dutt, Mittal, Reddy, Reddy, Reddy, Mr.M B N Rao. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 14 crore shares Securities has increased the revenue/EBITDA/PAT estimates of Apollo Hospitals Enterprise by ~1%/6%/7% for FY26 and 6%/13%/15% for FY27, factoring in faster growth and better margins in pharmacy business. The stock currently trades at EV/EBITDA of 27.4x FY26E and 22.3x FY27E. The brokerage maintains its ADD rating with a higher target price of Rs 7,500 (earlier Rs 6,700). ICICI Securities values the hospital business at 25x FY27E EV/EBITDA, HealthCo at 2.5x FY27E EV/sales and AHLL at 18x FY27E EV/EBITDA. Downside risks include higher competition in pharmacy business; and slower occupancy ramp up at new held 29.34 per cent stake in the company as of 31-Mar-2025, while FIIs owned 42.74 per cent, DIIs 22.1 per cent. (Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
India.com
2 hours ago
- India.com
Who is Tonmoy Sharma? CEO arrested in Rs 12440000000 crore fraud case in...
Indian-origin businessman Tonmoy Sharma has been arrested at Los Angeles International Airport for his role in a massive healthcare fraud case in the U.S., worth around Rs. 1,244 crore (USD 149 million). Sharma, 61, is the founder and former CEO of Sovereign Health Group, a now-closed organization that offered addiction recovery and mental health services. According to the U.S. Department of Justice, Sharma cheated health insurance companies by making fake claims totaling USD 149 million. He also paid about USD 21 million (roughly Rs. 175 crore) in illegal kickbacks to recruit patients for his centers. A federal grand jury has charged him with eight serious offenses including four counts of wire fraud, one conspiracy charge, and three counts related to illegal referrals. As per US Attorney's Office, Central District of California, Sovereign Health Group fraudulently enrolled patients into insurance plans without their knowledge, using deceptive tactics. The FBI began investigating the case in 2017. As part of the probe, they searched Sovereign Health's treatment centers in Southern California, its main office, and Sharma's home. The company shut down its operations in 2018. Another person involved in the case, Paul Jin Sen, has also been arrested. He has pleaded not guilty, and his trial is scheduled to begin on July 29. Who is Tonmoy Sharma? Tonmoy Sharma is originally from Guwahati, Assam. He studied medicine at Dibrugarh Medical College in 1987 and completed his internship at Safdarjung Hospital in Delhi. After that, he moved to the UK and later to the US, where he worked in the medical and research fields. He obtained his first medical licence from the Indian Medical Council in 1987, followed by a second from the General Medical Council of the United Kingdom in 1988. He is well known around the world for his research on schizophrenia and mental health issues. Over the years, he has published more than 200 research papers and has written five books. He is an internationally recognised research psychiatrist. His work focussed on brain function, cognition, and human behaviour in mental illnesses. Sharma has served on several editorial boards, been selected a peer reviewer for 14 international medical journals and served on various advisory boards governing the development of antipsychotics. Tanmay Sharma's father, Phani Sharma, was a well-known theatre artist, actor, and director in Assam. Phani Sharma is also the owner of Anuradha and the now defunct Rupayan and Anupama cinema halls.
Time of India
3 hours ago
- Time of India
HP to charge ₹10 consultation fee from patients in govt hospitals
Shimla: The Himachal Pradesh govt has decided to charge a consultation fee of Rs 10 from all patients at the time of registration in govt hospitals across the state. In a step to strengthen the Rogi Kalyan Samitis across the state, the govt, on the recommendations of the cabinet sub-committee, has authorised Rogi Kalyan Samitis to levy user charges on a need basis. This decision was made to improve the services undertaken by Rogi Kalyan Samitis, including sanitation, hygiene, and maintenance of infrastructure and equipment. The govt's decision to charge Rs 10 as a consultation fee from patients has come under criticism from the opposition Bharatiya Janata Party in the state. Former chief minister and the leader of the opposition, Jai Ram Thakur, said on Wednesday that there is nothing left on earth that the Sukhvinder Singh Sukhu-led Congress govt has not taxed. "When the central govt is providing free testing and treatment, why is the Sukhu govt taking it away?" questioned Thakur. The journey of this fee-imposing govt, which started with toilet tax, has now reached taxing the toilets and washrooms of hospitalised patients, quipped the leader of the opposition. The Sukhu govt has ordered the collection of money from every sick person who reaches the hospital for treatment in an emergency or helpless condition, he stated, adding that the govt must revoke this order at the earliest.
